A detailed history of St. Johns Investment Management Company, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, St. Johns Investment Management Company, LLC holds 51 shares of LLY stock, worth $38,505. This represents 0.02% of its overall portfolio holdings.

Number of Shares
51
Previous 111 54.05%
Holding current value
$38,505
Previous $100,000 55.0%
% of portfolio
0.02%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$772.14 - $960.02 $46,328 - $57,601
-60 Reduced 54.05%
51 $45,000
Q2 2024

Jul 25, 2024

BUY
$724.87 - $909.04 $43,492 - $54,542
60 Added 117.65%
111 $100,000
Q1 2024

Apr 15, 2024

SELL
$592.2 - $792.28 $9,475 - $12,676
-16 Reduced 23.88%
51 $39,000
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $19,432 - $22,907
37 Added 123.33%
67 $39,000
Q1 2020

Apr 27, 2020

BUY
$119.05 - $147.35 $3,571 - $4,420
30 New
30 $4,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track St. Johns Investment Management Company, LLC Portfolio

Follow St. Johns Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St. Johns Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on St. Johns Investment Management Company, LLC with notifications on news.